169 related articles for article (PubMed ID: 1906532)
1. A randomized double-blind study of gallium nitrate compared with etidronate for acute control of cancer-related hypercalcemia.
Warrell RP; Murphy WK; Schulman P; O'Dwyer PJ; Heller G
J Clin Oncol; 1991 Aug; 9(8):1467-75. PubMed ID: 1906532
[TBL] [Abstract][Full Text] [Related]
2. Gallium nitrate for acute treatment of cancer-related hypercalcemia. A randomized, double-blind comparison to calcitonin.
Warrell RP; Israel R; Frisone M; Snyder T; Gaynor JJ; Bockman RS
Ann Intern Med; 1988 May; 108(5):669-74. PubMed ID: 3282463
[TBL] [Abstract][Full Text] [Related]
3. Randomized, double-blind, phase II trial of gallium nitrate compared with pamidronate for acute control of cancer-related hypercalcemia.
Cvitkovic F; Armand JP; Tubiana-Hulin M; Rossi JF; Warrell RP
Cancer J; 2006; 12(1):47-53. PubMed ID: 16613662
[TBL] [Abstract][Full Text] [Related]
4. Gallium nitrate for acute treatment of cancer-related hypercalcemia: clinicopharmacological and dose response analysis.
Warrell RP; Skelos A; Alcock NW; Bockman RS
Cancer Res; 1986 Aug; 46(8):4208-12. PubMed ID: 3731088
[TBL] [Abstract][Full Text] [Related]
5. Treating cancer-related hypercalcemia with gallium nitrate.
Leyland-Jones B
J Support Oncol; 2004; 2(6):509-16. PubMed ID: 15605917
[TBL] [Abstract][Full Text] [Related]
6. Treatment of hypercalcemia of malignancy with intravenous etidronate. A controlled, multicenter study. The Hypercalcemia Study Group.
Singer FR; Ritch PS; Lad TE; Ringenberg QS; Schiller JH; Recker RR; Ryzen E
Arch Intern Med; 1991 Mar; 151(3):471-6. PubMed ID: 1900410
[TBL] [Abstract][Full Text] [Related]
7. Comparative study of pamidronate disodium and etidronate disodium in the treatment of cancer-related hypercalcemia.
Gucalp R; Ritch P; Wiernik PH; Sarma PR; Keller A; Richman SP; Tauer K; Neidhart J; Mallette LE; Siegel R
J Clin Oncol; 1992 Jan; 10(1):134-42. PubMed ID: 1727915
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of oral administration of etidronate disodium in maintaining normal serum calcium levels in previously hypercalcemic cancer patients.
Ringenberg QS; Ritch PS
Clin Ther; 1987; 9(3):318-25. PubMed ID: 3111705
[TBL] [Abstract][Full Text] [Related]
9. Update on the medical treatment of hypercalcemia of malignancy.
Hall TG; Schaiff RA
Clin Pharm; 1993 Feb; 12(2):117-25. PubMed ID: 8453860
[TBL] [Abstract][Full Text] [Related]
10. Role of the bisphosphonate etidronate in the therapy of cancer-related hypercalcemia.
Singer FR
Semin Oncol; 1990 Apr; 17(2 Suppl 5):34-9. PubMed ID: 2110387
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a 24-hour infusion of etidronate disodium for the treatment of hypercalcemia of malignancy.
Flores JF; Rude RK; Chapman RA; Belani CP; Chang AY; Pritchard JD; Hoff JV
Cancer; 1994 May; 73(10):2527-34. PubMed ID: 8174049
[TBL] [Abstract][Full Text] [Related]
12. Study in 25 patients shows gallium nitrate superior therapy for hypercalcemia in cancer patients.
Oncology (Williston Park); 1990 Oct; 4(10):57-8. PubMed ID: 2149825
[No Abstract] [Full Text] [Related]
13. Etidronate disodium in the management of malignancy-related hypercalcemia.
Hasling C; Charles P; Mosekilde L
Am J Med; 1987 Feb; 82(2A):51-4. PubMed ID: 3103436
[TBL] [Abstract][Full Text] [Related]
14. Etidronate disodium for treating hypercalcaemia of malignancy: a double blind, placebo-controlled study.
Hasling C; Charles P; Mosekilde L
Eur J Clin Invest; 1986 Oct; 16(5):433-7. PubMed ID: 3100312
[TBL] [Abstract][Full Text] [Related]
15. Intravenous etidronate in the management of malignant hypercalcemia.
Ryzen E; Martodam RR; Troxell M; Benson A; Paterson A; Shepard K; Hicks R
Arch Intern Med; 1985 Mar; 145(3):449-52. PubMed ID: 3919667
[TBL] [Abstract][Full Text] [Related]
16. Clinical trials of gallium nitrate in patients with cancer-related hypercalcemia.
Warrell RP
Semin Oncol; 1991 Aug; 18(4 Suppl 5):26-31. PubMed ID: 1925627
[No Abstract] [Full Text] [Related]
17. Effectiveness of a 24-hour infusion of etidronate disodium in the treatment of hypercalcemia of malignant disease. A dose-ranging pilot study.
Flores JF; Singer FR; Rude RK
Miner Electrolyte Metab; 1991; 17(6):390-5. PubMed ID: 1823390
[TBL] [Abstract][Full Text] [Related]
18. Treatment of cancer-related hypercalcemia: the role of gallium nitrate.
Leyland-Jones B
Semin Oncol; 2003 Apr; 30(2 Suppl 5):13-9. PubMed ID: 12776255
[TBL] [Abstract][Full Text] [Related]
19. Intravenous disodium etidronate therapy in Paget's disease of bone and hypercalcemia of malignancy. Effects on biochemical parameters and bone histomorphometry.
Meunier PJ; Chapuy MC; Delmas P; Charhon S; Edouard C; Arlot M
Am J Med; 1987 Feb; 82(2A):71-8. PubMed ID: 3103438
[TBL] [Abstract][Full Text] [Related]
20. Newer agents for the treatment of malignant hypercalcemia.
Kinirons MT
Am J Med Sci; 1993 Jun; 305(6):403-6. PubMed ID: 8506902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
